Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease
Kathleen M. Buchheit, Erin I. Lewis, Deborah Gakpo, Jonathan Hacker, Aaqib Sohail, Faith Taliaferro, Evans Berreondo Giron, Chelsea Asare, Marko Vukovic, Jillian C. Bensko, Daniel F. Dwyer, Alex K. Shalek, José Ordovás-Montañés, Tanya M. Laidlaw
Topics & Concepts
MepolizumabImmunologyProstaglandin D2EosinophilNasal polypsTryptaseLeukotrieneEosinophil cationic proteinMedicineEicosanoidBiologyInternal medicineProstaglandinAsthmaMast cellEnzymeArachidonic acidBiochemistryDrug-Induced Adverse ReactionsAsthma and respiratory diseasesSinusitis and nasal conditions